Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
Results of a Phase II Trial of Allogeneic Hematopoietic Stem Cell Transplantation Using 90Y-Ibritumomab Tiuxetan (Zevalin) in Combination With Fludarabine and Melphalan in Patients With High-Risk B-Cell Non-Hodgkin's Lymphoma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 10, 2023
Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial.
Journal: The Lancet. Haematology
Published: June 15, 2022
Treatment of allosensitized patients receiving allogeneic transplantation.
Journal: Blood advances
Published: March 29, 2021
Brentuximab vedotin and its use in the treatment of advanced Hodgkin's lymphoma.
Journal: Future oncology (London, England)
Published: July 18, 2020
Double-hit Signature with TP53 Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 19, 2020
Iron Overload Is Associated with Delayed Engraftment and Increased Nonrelapse Mortality in Recipients of Umbilical Cord Blood Hematopoietic Cell Transplantation.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: April 01, 2020
Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients: A Phase 2, Randomized Clinical Trial.
Journal: Annals of internal medicine
Published: February 11, 2020
Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Unrelated Donor Using Tacrolimus/Sirolimus-based GvHD Prophylaxis: Impact of HLA Mismatch.
Journal: Transplantation
Published: August 27, 2019
NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: June 15, 2019
Last Updated: 09/26/2026